CBLL CeriBell, Inc. logo

CBLL CeriBell, Inc.

Healthcare
$18.89+0.00%OpenMarket Cap: $716.7M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

PEG

P/B

5.02

P/S

7.49

EV/EBITDA

-11.63

DCF Value

$-41.83

FCF Yield

-7.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

87.7%

Operating Margin

-68.3%

Net Margin

-63.5%

ROE

-38.2%

ROA

-33.9%

ROIC

-39.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$26.5M$-19.7M$
Q4 null$24.8M$-13.5M$
FY null$89.1M$-53.4M$
Q3 null$22.6M$-13.5M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$27.50

Target (Median)

$27.50

Target Range

$25.00 - $30.00

1 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Canaccord GenuityBuy
2026-05-12
BTIGBuy
2026-01-28
Canaccord GenuityBuy
2025-12-17
BTIGBuy
2025-12-15
TD CowenBuy
2025-11-05

Trading Activity

Insider Trades

View All
Chao Xingjuandirector, officer: President and CEO
SellThu May 07
Chao Xingjuandirector, officer: President and CEO
SellThu May 07
Chao Xingjuandirector, officer: President and CEO
SellThu May 07
Chao Xingjuandirector, officer: President and CEO
SellThu May 07
Woo Raymondofficer: Chief Technology Officer
SellMon May 04

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.99

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

Peers